SeekingAlpha · Aug 4, 2026
Bruker Corporation (BRKR) Q2 2026 Earnings Call Transcript
Bruker Corporation (BRKR) Q2 2026 Earnings Call August 4, 2026 9:00 AM EDTCompany ParticipantsJoe KostkaFrank Laukien - Chairman, CEO & PresidentGerald...
BR
NASDAQ · BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
Healthcare · Medical - Devices
$415.16
Up+$19.97 (+4.81%)
Updated Sep 2, 2026, 2:21 PM
SID Score
6.5/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 54.39B
- P/E ratio
- -355.31
- Dividend yield
- 0.43%
- 52-week range
- $264.30 – $474.99
- Volume
- 1.72K
- Avg. volume
- 27.82K
Price performance
BRKRP price history
1M range · 21 trading sessions · Daily adjusted prices
BRKRP closed at $415.16 after 21 trading sessions, up 9.35% for the selected period.
- Last close
- $415.16
- Period change
- +9.35%
- Period low
- $379.65
- Period high
- $440.61
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 1, 2026 | $422.33 | $428.01 | $415.16 | $415.16 | 1.72K |
| Aug 31, 2026 | $421.31 | $430.16 | $417.41 | $428.01 | 7.9K |
| Aug 28, 2026 | $433.19 | $433.21 | $420.32 | $420.32 | 950.46 |
| Aug 27, 2026 | $433.36 | $437.40 | $431.11 | $437.40 | 1.1K |
| Aug 26, 2026 | $419.29 | $424.22 | $419.29 | $424.22 | 757.36 |
| Aug 25, 2026 | $415.50 | $423.01 | $415.50 | $423.01 | 472.21 |
| Aug 24, 2026 | $424.74 | $424.74 | $422.29 | $422.29 | 2.98K |
| Aug 21, 2026 | $434.52 | $441.54 | $429.27 | $439.40 | 4.78K |
| Aug 20, 2026 | $433.52 | $440.61 | $432.83 | $440.61 | 1.12K |
| Aug 19, 2026 | $445.12 | $445.12 | $433.89 | $434.20 | 6.1K |
| Aug 18, 2026 | $428.24 | $428.24 | $420.21 | $420.21 | 3.06K |
| Aug 17, 2026 | $422.83 | $426.14 | $422.83 | $424.62 | 8.58K |
| Aug 14, 2026 | $423.175 | $428.32 | $423.175 | $425.41 | 4.17K |
| Aug 13, 2026 | $432.61 | $433.46 | $432.61 | $433.26 | 1.14K |
| Aug 12, 2026 | $424.20 | $437.99 | $424.20 | $437.99 | 984.73 |
| Aug 11, 2026 | $421.86 | $427.02 | $419.44 | $427.02 | 13.27K |
| Aug 10, 2026 | $409.30 | $418.77 | $409.30 | $418.44 | 6.06K |
| Aug 7, 2026 | $391.26 | $400.35 | $391.26 | $400.35 | 2.85K |
| Aug 6, 2026 | $386.58 | $389.04 | $384.90 | $386.57 | 1.19K |
| Aug 5, 2026 | $390.77 | $391.10 | $390.77 | $391.10 | 47.03K |
| Aug 4, 2026 | $395.61 | $401.86 | $379.65 | $379.65 | 6.83K |
Latest BRKRP news
The latest Smart Investors Daily articles mentioning BRKRP.
Stock researchCompany · Overview
BRKRP research
Overview
Company profile and research snapshot.
Company profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 12
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 5, 2026 | Citigroup | Neutral | — |
| Jul 8, 2026 | Citigroup | Neutral | — |
| Jul 7, 2026 | Leerink Partners | Outperform | — |
| Jun 29, 2026 | Guggenheim | Buy | — |
| Jun 24, 2026 | Barclays | Overweight | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 4, 2026
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares increased by
Yahoo · Jul 28, 2026
3 Reasons to Sell BRKR and 1 Stock to Buy Instead
Bruker’s 26.8% return over the past six months has outpaced the S&P 500 by 20.6%, and its stock price has climbed to $60.45 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
SeekingAlpha · Feb 13, 2026
Bruker Corporation 2025 Q4 - Results - Earnings Call Presentation
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
